Bromazine
Not to be confused with Promazine.
Clinical data | |
---|---|
MedlinePlus | a682065 |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | High |
Protein binding | 96% |
Metabolism | Mostly hepatic (CYP-mediated), also renal |
Elimination half-life | 1 to 4 hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.003.854 |
Chemical and physical data | |
Formula | C17H20BrNO |
Molar mass | 334.257 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
NY (what is this?) (verify) |
Bromazine (trade names Ambodryl,[1] Ambrodil and others), also known as bromodiphenhydramine, is an antihistamine and anticholinergic.[2] It is a brominated form of diphenhydramine.
References
- ↑ Baker CE (1974). Physicians' Desk Reference (28 ed.). Oradell, NJ 07649: Medical Economics Company. pp. 1076, 1081.
{{cite book}}
: CS1 maint: location (link) - ↑ Maclaren WR, Bruff WC, Eisenberg BC, Weiner H, Martin WH (1955). "A clinical comparison of carbinoxamine maleate, tripelennamine hydrochloride, and bromodiphenhydramine hydrochloride in treating allergic symptoms". Annals of Allergy. 13 (3): 307–12. PMID 14377226.
Benzimidazoles (*) | |
---|---|
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
Histamine receptor modulators | |||||
---|---|---|---|---|---|
H1 |
| ||||
H2 |
| ||||
H3 |
| ||||
H4 |
| ||||
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors |
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.